- Trials with a EudraCT protocol (83)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
83 result(s) found for: Mean airway pressure.
Displaying page 5 of 5.
| EudraCT Number: 2009-016757-18 | Sponsor Protocol Number: CCD-0807-PR-0024 | Start Date*: 2011-10-11 | |||||||||||
| Sponsor Name:Chesi Farmaceutici SpA | |||||||||||||
| Full Title: A phase III, 12-week, multicentre, multinational, randomised, double-blind, double-dummy, 3 arm-parallel group study to test the efficacy of CHF 1535 50/6 μg (fixed combination of beclomethasone di... | |||||||||||||
| Medical condition: Asthma | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) FR (Ongoing) HU (Completed) SK (Completed) ES (Completed) BG (Completed) IT (Prematurely Ended) Outside EU/EEA | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-022791-31 | Sponsor Protocol Number: D01092010AZNTG | Start Date*: Information not available in EudraCT | |||||||||||||||||||||||||||||||
| Sponsor Name:University Erlangen-Nuremberg | |||||||||||||||||||||||||||||||||
| Full Title: Contrast sensitivity of patients with normal tension glaucoma by application of Azarga® | |||||||||||||||||||||||||||||||||
| Medical condition: The effect of AZARGA(R) on the central and spacial-temporal contrast sensitivity of patients with normal tension glaucoma will be examined. Healthy controls are required to prove the disease specif... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
| Trial protocol: DE (Ongoing) | |||||||||||||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||||||||||||
| EudraCT Number: 2005-005615-21 | Sponsor Protocol Number: 205.341 | Start Date*: 2006-07-13 | |||||||||||
| Sponsor Name:Boehringer Ingelheim Pharma GmbH & Co. KG | |||||||||||||
| Full Title: A Randomised, Double-Blind, Placebo-Controlled, Crossover Efficacy and Safety Evaluation of 8-Week Treatment Periods of Two Doses [5 µg (2 actuations of 2.5 µg) and µg (2 actuations of 5 µg)] of Ti... | |||||||||||||
| Medical condition: Patients with severe persistent asthma | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) DK (Completed) NL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.